Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
33
CRBG Quote, Financials, Valuation and Earnings
Last price:
$29.66
Seasonality move
:
-0.18%
Day range:
$28.66 - $29.91
52-week range:
$21.50 - $34.66
Dividend yield:
3.1%
P/E ratio:
8.49x
P/S ratio:
1.23x
P/B ratio:
1.23x
Volume:
5M
Avg. volume:
4.5M
1-year change:
37.31%
Market cap:
$16.8B
Revenue:
$19.1B
EPS (TTM):
-$2.03
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $13.2B | $15.1B | $23.6B | $25.8B | $19.1B | |
| Revenue Growth (YoY) | -- | 14.02% | 56.44% | 9.39% | -25.94% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $2B | $2B | $2.1B | $2.3B | $2.4B | |
| Other Inc / (Exp) | $497M | $519M | $578M | $550M | $417M | |
| Operating Expenses | $1.9B | $1.9B | $4.9B | $2.4B | $3.2B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | $555M | $490M | $389M | $534M | $580M | |
| EBT. Incl. Unusual Items | $139M | $851M | $11.3B | $10.5B | $940M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -$168M | -$15M | $2.1B | $2B | -$96M | |
| Net Income to Company | $307M | $866M | $9.2B | $8.5B | $1B | |
| Minority Interest in Earnings | -$257M | -$224M | -$929M | -$320M | $68M | |
| Net Income to Common Excl Extra Items | $50M | $642M | $8.2B | $8.2B | $1.1B | |
| Basic EPS (Cont. Ops) | $0.08 | $1.00 | $12.78 | $12.63 | $1.72 | |
| Diluted EPS (Cont. Ops) | $0.08 | $1.00 | $12.78 | $12.60 | $1.71 | |
| Weighted Average Basic Share | $645M | $645M | $645M | $646.1M | $643.3M | |
| Weighted Average Diluted Share | $645M | $645M | $645M | $647.4M | $645.2M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | $694M | $1.3B | $11.6B | $11B | $1.5B | |
| Revenue (Reported) | $13.2B | $15.1B | $23.6B | $25.8B | $19.1B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | $694M | $1.3B | $11.6B | $11B | $1.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $5.5B | $7B | $6B | $2B | |
| Revenue Growth (YoY) | -- | -- | 27.91% | -15.1% | -66.08% | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $521M | $578M | $611M | $492M | |
| Other Inc / (Exp) | -- | $144M | $130M | $107M | $172M | |
| Operating Expenses | -- | $603M | $642M | $660M | $504M | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $83M | $149M | $135M | $133M | |
| EBT. Incl. Unusual Items | -- | $2B | $3.2B | $2.5B | -$1.6B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $381M | $640M | $392M | -$407M | |
| Net Income to Company | -- | $1.6B | $2.5B | $2.1B | -$1.2B | |
| Minority Interest in Earnings | -- | -$152M | -$126M | $32M | $3M | |
| Net Income to Common Excl Extra Items | -- | $1.4B | $2.4B | $2.1B | -$1.2B | |
| Basic EPS (Cont. Ops) | -- | $2.20 | $3.73 | $3.29 | -$2.02 | |
| Diluted EPS (Cont. Ops) | -- | $2.20 | $3.72 | $3.28 | -$2.02 | |
| Weighted Average Basic Share | -- | $645M | $645.7M | $639M | $587.1M | |
| Weighted Average Diluted Share | -- | $645M | $646.4M | $641M | $587.1M | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | $2B | $3.3B | $2.6B | -$1.5B | |
| Revenue (Reported) | -- | $5.5B | $7B | $6B | $2B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | $2B | $3.3B | $2.6B | -$1.5B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | -- | $28.5B | $20.6B | $14.9B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | -- | $2.3B | $2.4B | $2.2B | |
| Other Inc / (Exp) | -- | $433M | $584M | $435M | $441M | |
| Operating Expenses | -- | -- | $5.4B | $2.6B | $3.1B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $295M | $451M | $618M | $548M | |
| EBT. Incl. Unusual Items | -- | -- | $16.5B | $2.4B | -$1.9B | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | -- | $3.3B | $197M | -$535M | |
| Net Income to Company | -- | -- | $13.3B | $2.2B | -$1.4B | |
| Minority Interest in Earnings | -- | -$312M | -$898M | $7M | $100M | |
| Net Income to Common Excl Extra Items | -- | -- | $12.4B | $2.2B | -$1.3B | |
| Basic EPS (Cont. Ops) | -- | -- | $19.19 | $3.43 | -$2.02 | |
| Diluted EPS (Cont. Ops) | -- | -- | $19.18 | $3.40 | -$2.03 | |
| Weighted Average Basic Share | -- | -- | -- | -- | -- | |
| Weighted Average Diluted Share | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | -- | $17B | $3B | -$1.3B | |
| Revenue (Reported) | -- | -- | $28.5B | $20.6B | $14.9B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | -- | $17B | $3B | -$1.3B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Revenue | -- | $16.5B | $21.4B | $16.2B | $12B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | -- | $1.6B | $1.7B | $1.8B | $1.6B | |
| Other Inc / (Exp) | -- | $433M | $439M | $324M | $348M | |
| Operating Expenses | -- | $1.4B | $1.8B | $2B | $1.9B | |
| Operating Income | -- | -- | -- | -- | -- | |
| Net Interest Expenses | -- | $295M | $357M | $441M | $409M | |
| EBT. Incl. Unusual Items | -- | $5.5B | $10.8B | $2.7B | -$122M | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | -- | $959M | $2.2B | $336M | -$103M | |
| Net Income to Company | -- | $4.5B | $8.6B | $2.4B | -$19M | |
| Minority Interest in Earnings | -- | -$312M | -$281M | $46M | $78M | |
| Net Income to Common Excl Extra Items | -- | $4.2B | $8.4B | $2.4B | $59M | |
| Basic EPS (Cont. Ops) | -- | $6.56 | $12.97 | $3.77 | -$0.01 | |
| Diluted EPS (Cont. Ops) | -- | $6.56 | $12.96 | $3.76 | -$0.02 | |
| Weighted Average Basic Share | -- | $1.9B | $1.9B | $1.9B | $1.8B | |
| Weighted Average Diluted Share | -- | $1.9B | $1.9B | $1.9B | $1.8B | |
| EBITDA | -- | -- | -- | -- | -- | |
| EBIT | -- | $5.8B | $11.2B | $3.1B | $287M | |
| Revenue (Reported) | -- | $16.5B | $21.4B | $16.2B | $12B | |
| Operating Income (Reported) | -- | -- | -- | -- | -- | |
| Operating Income (Adjusted) | -- | $5.8B | $11.2B | $3.1B | $287M | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | $654M | $537M | $552M | $612M | |
| Short Term Investments | -- | $207.2B | $204B | $161.2B | $170.9B | |
| Accounts Receivable, Net | -- | $860M | $884M | $916M | $594M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | $208.7B | $205.5B | $162.7B | $172.1B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | $208.6B | $206.4B | $165.1B | $175.5B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | $410.2B | $416.2B | $360.3B | $379.3B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | $36.8B | $43.5B | $28.1B | $26.2B | |
| Long-Term Debt | -- | $11.2B | $7.4B | $13.8B | $11.6B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | $370.3B | $387.3B | $350B | $366.6B | |
| Common Stock | -- | $6M | $6M | $6M | $6M | |
| Other Common Equity Adj | -- | $14.7B | $10.2B | -$16.9B | -$13.5B | |
| Common Equity | -- | $37.2B | $27.1B | $9.4B | $11.8B | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | $2.6B | $1.8B | $939M | $869M | |
| Total Equity | -- | $39.8B | $28.9B | $10.3B | $12.6B | |
| Total Liabilities and Equity | -- | $410.2B | $416.2B | $360.3B | $379.3B | |
| Cash and Short Terms | -- | $207.8B | $204.6B | $161.7B | $171.5B | |
| Total Debt | -- | $11.2B | $15.7B | $15.3B | $11.9B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | -- | -- | $382M | $569M | $530M | |
| Short Term Investments | -- | -- | $156.2B | $156.1B | $65.5B | |
| Accounts Receivable, Net | -- | -- | $695M | $717M | $690M | |
| Inventory | -- | -- | -- | -- | -- | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | -- | -- | -- | -- | -- | |
| Total Current Assets | -- | -- | $157.3B | $157.4B | $66.7B | |
| Property Plant And Equipment | -- | -- | -- | -- | -- | |
| Long-Term Investments | -- | -- | $161.1B | $160.4B | $188.7B | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | $354.6B | $355.6B | $399.4B | |
| Accounts Payable | -- | -- | -- | -- | -- | |
| Accrued Expenses | -- | -- | -- | -- | -- | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | -- | -- | $28.1B | $25.3B | $25.9B | |
| Long-Term Debt | -- | -- | $13.9B | $11B | $12B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | $346.2B | $346.3B | $385B | |
| Common Stock | -- | -- | $6M | $6M | $7M | |
| Other Common Equity Adj | -- | -- | -$17.3B | -$19.3B | -$9.9B | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | $862M | $890M | $834M | |
| Total Equity | -- | -- | $8.4B | $9.3B | $14.4B | |
| Total Liabilities and Equity | -- | -- | $354.6B | $355.6B | $399.4B | |
| Cash and Short Terms | -- | -- | $156.6B | $156.7B | $66B | |
| Total Debt | -- | -- | $15.4B | $12B | $12B | |
| Period Ending | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $307M | $866M | $9.2B | $8.5B | $1B | |
| Depreciation & Amoritzation | $294M | $325M | $413M | $585M | $366M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $2.4B | $3.3B | $2.4B | $2.6B | $3.4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -$77M | -- | $1.1B | -$107M | $742M | |
| Cash From Investing | -$10.4B | -$7.9B | -$2B | -$7.3B | -$5.5B | |
| Dividends Paid (Ex Special Dividend) | -$1.6B | -$472M | -$1.6B | -$876M | -$1.7B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | $3.5B | $2.3B | $5B | $9.9B | $1.5B | |
| Long-Term Debt Repaid | -$1.6B | -$2.5B | -$5.9B | -$9.5B | -$1.8B | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$498M | |
| Other Financing Activities | $5.7B | $4.6B | $1.7B | $5.8B | $5.2B | |
| Cash From Financing | $7.9B | $4.7B | -$753M | $4.7B | $2.1B | |
| Beginning Cash (CF) | $838M | $827M | $918M | $601M | $633M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$11M | $84M | -$315M | $42M | -$5M | |
| Ending Cash (CF) | $827M | $918M | $601M | $633M | $628M | |
| Levered Free Cash Flow | $2.4B | $3.3B | $2.4B | $2.6B | $3.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $1.6B | $2.5B | $2.1B | -$1.2B | |
| Depreciation & Amoritzation | -- | $187M | $139M | $107M | $36M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $603M | $1.6B | $1B | $83M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | $137M | -- | -- | -- | |
| Cash From Investing | -- | -$1.5B | -$875M | -$2.4B | -$6.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -$112M | -- | -$146M | -$133M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | $936M | $2.6B | $552M | $774M | |
| Long-Term Debt Repaid | -- | -$941M | -$2B | -$584M | -$504M | |
| Repurchase of Common Stock | -- | -- | -- | -$46M | -$715M | |
| Other Financing Activities | -- | $1B | $1.9B | $1.2B | $3.1B | |
| Cash From Financing | -- | $930M | -$820M | $1.2B | $6B | |
| Beginning Cash (CF) | -- | $995M | $529M | $788M | $653M | |
| Foreign Exchange Rate Adjustment | -- | -- | -$5M | -- | -- | |
| Additions / Reductions | -- | $7M | -$80M | -$169M | -$106M | |
| Ending Cash (CF) | -- | $566M | $444M | $581M | $547M | |
| Levered Free Cash Flow | -- | $603M | $1.6B | $1B | $83M | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | $13.3B | $2.2B | -$1.4B | |
| Depreciation & Amoritzation | -- | -- | $304M | $469M | $152M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | $2.5B | $3.1B | $1.4B | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | $137M | $840M | $27M | $1.3B | |
| Cash From Investing | -- | -- | -$2.3B | -$7.2B | -$12.4B | |
| Dividends Paid (Ex Special Dividend) | -- | -$1B | -$1.1B | -$1.1B | -$1.3B | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | $10.8B | $784M | $1.6B | |
| Long-Term Debt Repaid | -- | -- | -$10.6B | -$1B | -$1.8B | |
| Repurchase of Common Stock | -- | -- | -- | -$246M | -$1.6B | |
| Other Financing Activities | -- | -- | $3.6B | $5.4B | $9.7B | |
| Cash From Financing | -- | -- | -$818M | $4.3B | $10.9B | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -$548M | $173M | -$69M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | $2.5B | $3.1B | $1.4B | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | $4.5B | $8.6B | $2.4B | -$19M | |
| Depreciation & Amoritzation | -- | $571M | $462M | $346M | $132M | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | $2B | $2.2B | $2.6B | $672M | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | $137M | -$107M | $27M | $577M | |
| Cash From Investing | -- | -$3B | -$3.3B | -$3.3B | -$10.2B | |
| Dividends Paid (Ex Special Dividend) | -- | -$1B | -$580M | -$846M | -$415M | |
| Special Dividend Paid | -- | -- | -- | $620K | -- | |
| Long-Term Debt Issued | -- | $4.1B | $9.8B | $698M | $875M | |
| Long-Term Debt Repaid | -- | -$4.7B | -$9.4B | -$874M | -$902M | |
| Repurchase of Common Stock | -- | -- | -- | -$246M | -$1.4B | |
| Other Financing Activities | -- | $2.8B | $4.7B | $4.2B | $8.7B | |
| Cash From Financing | -- | $1.1B | $1B | $660M | $9.4B | |
| Beginning Cash (CF) | -- | $3B | $1.7B | $1.9B | $1.7B | |
| Foreign Exchange Rate Adjustment | -- | -$1M | -$9M | $3M | -- | |
| Additions / Reductions | -- | $85M | -$148M | -$17M | -$81M | |
| Ending Cash (CF) | -- | $2.6B | $1.6B | $1.9B | $1.6B | |
| Levered Free Cash Flow | -- | $2B | $2.2B | $2.6B | $672M | |
Get CRBG Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
CRBG
Sector
P/E ratio
8.49x
11.99x
PEG ratio
--
0.36x
P/B ratio
1.23x
1.05x
Price / LTM sales
1.23x
2.55x
Growth Metrics
CRBG
Sector
Revenue growth
-66.08%
6.08%
Earnings growth
-50%
6.45%
Revenue (5-year growth)
--
5.85%
Earnings forecast
$1.16
$0.56
Profitability
CRBG
Sector
Profitability FY 2024
--
$179.9M
Return on invested capital
-5.21%
5.27%
Return on assets
-0.33%
0.98%
Return on equity
-10.33%
9.43%
Earnings Date
Last Earnings Date
Nov
4
Next Earnings Date
Feb
14
Estimated Next Earnings Date
Feb
3
Balance Sheet
CRBG
Sector
Total cash
$66B
$615.3M
Short term investments
$170.9B
$408.4M
Total assets
$379.3B
$4.5B
Long term debt
$12B
$270.8M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
